Cardea Bio | Linking up to Life - Innovation Partnership ......CRISPR QC: Website CRISPR-BIND...
Transcript of Cardea Bio | Linking up to Life - Innovation Partnership ......CRISPR QC: Website CRISPR-BIND...
Linking up to LifePartner with Cardea to Discover Biological Insight
Our technology can be fully tailored to meet your specific needs across all dimensions: hardware, software, assay, regulatory, and application.
FULLY CUSTOMIZABLE
Our dedicated team is committed to our mutual success every step of the way from product design to milestone completion and meeting your timelines.
Cardean Transistors™ & Tech+Bio Infrastructure Cardea’s Tech+Bio Infrastructure consists of an extensive list of Tech+Bio modules with proprietary Biology-gated Transistors, or Cardean Transistors™, at its core. These transistors are used to build chipsets, such as CRISPR-Chip™, that can be integrated into thousands of potential products and applications to be used in the field, at the bedside, or at the bench. Because of the infinite applications this revolution can enable, we have structured our Innovation Partnership Program to bring this revolutionary technology to you and your customers. To learn more, contact us at [email protected].
True Multi-omics Detection
Select the right guideOPTIMAL CONDITIONS
CRISPR-BIND identifies specificity, performance, and the most optimal conditions to ensure the most robust guide is selected for CRISPR experiments.
Assess gRNA - Cas9 interactionsOPTIMIZED CRISPR DESIGNS
CRISPR-BIND is a rapid, high value quality control technology to assess gRNA - CAS interactions and allow researchers to optimize CRISPR designs.
Ken Dickerson / CRISPR Group Leader / CRISPR QC
The Cardea team provided a complete infrastructure solution to quickly bring CRISPR-BIND to market. I can’t wait to see where we go next.
Rapid & Accurate Quality Controlof Your CRISPR Experiments.
In Partnership with CRISPR QCCase Study: CRISPR-BIND
CRISPR QC is on a mission to revolutionize the quality, safety, and e�ciency of genome editing. Developed on the Tech+Bio Infrastructure with the full support of the Cardea team, CRISPR-BIND is an automated liquid handler that doesn’t use optics or labels to perform quality control of CRISPR assays. Integrated with Opentrons’ OT-2, CRISPR-BIND is an all-electronic system that’s easy to run and tailored for your specific CRISPR assay needs without the need of expensive lab reagents or time-demanding lab protocols. CRISP QC found in Cardea a reliable platform with the proven ability to deliver a commercial product with the scalability for a global impact.
“
CRISPR QC:
Website
CRISPR-BIND Brochure
CRISPR QC Intro deck
Publications:
List of other Cardea publications
Nature Biomedical Engineering:CRISPR-Chip paper
KEN DICKERSONCRISPR Group LeaderCRISPR [email protected]
DR. FRANCIE BARRONVP, Innovation [email protected]
Cardea Innovation Partnership Program:
Introduction Deck Website
The Tech+Bio Infrastructure is only available to Cardea’s Innovation Partners. Learn more via the links below:
Contact:
More Information
To learn more about CRISPR-BIND or the Cardea Innovation Partnership Program and how to become a partner please email corresponding person below.